---
layout: page
title: Publications
permalink: /publications/
navigation_weight: 4
---

17. Wang, S.**#**, **Pitt, J. J.#**, Zheng, Y., Yoshimatsu, T. F., Gao, G., Sanni, A., Oluwasola, O. ... White, K. P., Huo, D., Olopade, O. I. Germline variants and somatic mutation signatures of breast cancer across populations of African and European ancestry in the US and Nigeria. *International Journal of Cancer*. In revision.

16. Baughman, M., Chard, R., Ward, L., **Pitt, J. J.**, Chard, K., & Foster, I. T. (2018). Profiling and Predicting Application Performance on the Cloud. *IEEE Utility and Cloud Computing Conference*. In Press.

15. **Pitt, J. J.#**, Riester, M.**#**, Zheng, Y., Yoshimatsu, T. F., Sanni, A., Oluwasola, O., … Barretina, J. (2018). Characterization of Nigerian breast cancer reveals prevalent homologous recombination deficiency and aggressive molecular features. *Nature Communications*, 9(1), 4181.

14. **Pitt, J. J.**, Zheng, Y., & Olopade, O. I. (2018). Genetic Ancestry May Influence the Evolutionary Trajectory of Cancers. *Cancer Cell*, 34(4), 529–530.

13. Pitroda, S. P., Khodarev, N. N., Huang, L., Uppal, A., Wightman, S. C., Ganai, S., Joseph, N., **Pitt, J.** … Weichselbaum, R. R. (2018). Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis. *Nature Communications*, 9(1), 1793.

12. Cheng, J., Demeulemeester, J., Wedge, D. C., Vollan, H. K. M., **Pitt, J. J.**, Russnes, H. G., … Van Loo, P. (2017). Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors. *Nature Communications*, 8(1), 1221.

11. Huo, D., Hu, H., Rhie, S. K., Gamazon, E. R., Cherniack, A. D., Liu, J., Yoshimatsu, T., **Pitt, J.J.** … Olopade, O. I. (2017). Comparison of Breast Cancer Molecular Features and Survival by African and European Ancestry in The Cancer Genome Atlas. *JAMA Oncol*. 3(12): 1654-1662.

10. Ou, O., Huppi, K., Chakka, S., Gehlhaus, K., Dubois, W., Patel, J., Chen, J., Mackiewicz, M., Jones, T. L., **Pitt, J. J.**, Martin, S. E. , Goldsmith, P., Simmons, J. K., Mock, B. A., &  Caplen, N. J. (2014) Loss-of-function RNAi Screens in Breast Cancer Cells Identify AURKB, PLK1, PIK3R1, MAPK12, PRKD2, and PTK6 as Sensitizing Targets of Rapamycin Activity. *Cancer Letters*. 354(2): 336-47.

9. Garimella, S. V., Gehlhaus, K., Dine, J. L., **Pitt, J. J.**, Grandin, M., Chakka, S., Nau, M. M., Caplen, N. J., &  Lipkowitz, S. (2014). Identification of Novel Molecular Regulators of Tumor Necrosis Factor-related apoptosis-inducing Ligand (TRAIL)-induced apoptosis in Breast Cancer Cells by RNAi Screening. *Breast Cancer Research*. 16(2): R41.

8. Camps, J., **Pitt, J. J.**, Emons, G., Hummon, A. B., Case, C. M., Grade, M., … Ried, T. (2013). Genetic amplification of the NOTCH modulator LNX2 upregulates the WNT/β-catenin pathway in colorectal cancer. *Cancer Research*, 73(6), 2003–2013.

7. Huppi, K., **Pitt, J. J.**, Wahlberg, B. H., & Caplen, N. J. (2012). The 8q24 Gene Desert: an Oasis of Transcriptional Activity. *Frontiers in Genetics*. 3 (69).

6. Hummon, A. B., **Pitt, J. J.**, Camps, J., Emons, G., Skube, S. B., Huppi, K., … Caplen, N. J. (2012). Systems-wide RNAi analysis of CASP8AP2/FLASH shows transcriptional deregulation of the replication-dependent histone genes and extensive effects on the transcriptome of colorectal cancer cells. *Molecular Cancer*, 11, 1.

5. Mackiewicz, M., Huppi, K., **Pitt, J. J.**, Dorsey, T. H., Ambs, S., & Caplen, N. J. (2011). Identification of the receptor tyrosine kinase AXL in breast cancer as a target for the human miR-34a microRNA. *Breast Cancer Research and Treatment*, 130(2), 663–679.

4. Uckun FM, Qazi S, Ozer Z, Garner AL, **Pitt J**, Ma H, & Janda KD. 2011. Inducing Apoptosis in Chemotherapy-resistant B-lineage Acute Lymphoblastic Leukemia (ALL) Cells by Targeting GRP78/HSPA5, a Master Regulator of the Anti-apoptotic Unfolded Protein Response (UPR) Signaling Network. *British Journal of Haematology*. 153 (6): 741-52.

3. Huppi, K., **Pitt, J.**, Wahlberg, B., & Caplen, N. J. (2011) Genomic Instability and Mouse miRNAs. *Toxicology Mechanisms & Methods*. 21 (4): 325-33.

2. Uckun, F. M., **Pitt, J.**, & Qazi, S. (2010). Constitutively Active Janus Kinase 3 Pathway in Human Acute B-precursor Leukemia is Associated with Steroid Resistance. *Expert Review of Anticancer Therapy*. 11 (1): 37-48.

1. **Pitt, J. J.** & Qazi, S. (2010). Phenotypes for Prediction: Gene Expression and Genetic Exceptionalism. *eJournal of Biological Sciences*. 1 (2): 52-64.

**\# - indicates co-first authorship**
